Ad is loading...
MSRFX
Price
$16.22
Change
+$0.04 (+0.25%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

MSRFX vs RNWFX

Header iconMSRFX vs RNWFX Comparison
Open Charts MSRFX vs RNWFXBanner chart's image
Morgan Stanley Inst Next Gen Em Mkts R6
Price$16.22
Change+$0.04 (+0.25%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
MSRFX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSRFX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSRFX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. MSRFX (21.6M). RNWFX pays higher dividends than MSRFX: RNWFX (1.51) vs MSRFX (1.33). MSRFX was incepted earlier than RNWFX: MSRFX (10 years) vs RNWFX (23 years). MSRFX (33.00) and RNWFX (32.00) have comparable annual turnover. RNWFX has a lower initial minimum investment than MSRFX: RNWFX (250) vs MSRFX (5000000). MSRFX annual gain was more profitable for investors over the last year : 13.44 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. MSRFX (-1.88).
MSRFXRNWFXMSRFX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years23 years-
Gain YTD9.4477.099133%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.6M60.9B0%
Annual Yield % from dividends1.331.5188%
Returns for 1 year13.4411.54116%
Returns for 3 years-33.51-14.55230%
Returns for 5 years-1.8817.17-11%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics